drugset / Trial / NCT03448172
Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of the study is to characterize the absorption, distribution, metabolism, and excretion (ADME) of a single oral dose of \[14C\]PF-05221304 in Healthy Adult Male Subjects
Timeline
- Start
- 2018-04-18
- Primary completion
- 2018-05-26
- Completion
- 2018-06-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clesacostat | Small molecule | 50 mg | Oral |
Indications
No indication recorded.